Jaegil Kim

Jaegil Kim is a Clinical Bioinformatics Director at GSK since January 2019, specializing in biomarker discovery and genomic signature characterization, particularly related to Niraparib and homologous recombination deficiency. In previous roles, Jaegil Kim served as a Senior Computational Scientist II at the Broad Institute from July 2011 to January 2019, contributing to large-scale cancer genome analysis and the development of significant computational tools, including "SignatureAnalyzer" for mutational signature analysis. Prior experience includes a Senior Research Associate position at Boston University, focusing on computer simulation algorithms for biomolecules, and research staff roles at the Japan Biological Information Research Center, working on computational methods for protein analysis. Jaegil Kim holds a Ph.D. in Physical Chemistry from the Korea Advanced Institute of Science and Technology, completed in 2000. Select publications include contributions to esteemed journals in molecular dynamics and cancer genomics.